In June 2011, the FDA issued a warning
to doctors about potential side effects of Zocor when used at high doses (80 mg),
saying that the cholesterol drug may increase the risk of Zocor muscle injury or myopathy. The warning came after more than a year of FDA experts reviewing
clinical trials on Zocor and other drugs containing simvastatin, which had been
available to the manufacturers for some time. The FDA
warns that the 80 mg dose of Zocor carries an increased risk of muscle injury,
Friday, October 28, 2011
Wednesday, October 26, 2011
80mg Dose of Zocor Now Comes With Strong Warning of Muscle Damage

With a long history of increased risk for Zocor muscle injury,
the drug's label has recently been amended by the FDA. The
FDA’s new recommendation was prompted by a seven-year study and patient reports
that prove those taking the higher dosage of simvastatin have a greater risk of
muscle injury and other Zocor side effects than patients treated with lower doses or other statins. The new
restrictions and warnings also apply to Vytorin and Simcor, which are
combination medications that include
Thursday, October 13, 2011
FDA Warns Of Deadly Link to Rare Muscle Syndrome with Zocor
People taking the highest approved doses of the cholesterol-lowering drug Zocor (simvastatin) may be at
increased risk for muscle injuries, the U.S. Food and Drug Administration (FDA)
warned earlier this year. The Zocor drug safety communication also contains a list of drugs that
should not be used in combination with Zocor, including the combination
cholesterol drugs Vytorin and Simcor. The FDA began reviewing the side effects of Zocor in March 2010, when it first warned of
the possible increased risk of rhabdomyolysis and other muscle injuries. The FDA estimates that 2.1 million people were
prescribed some drug containing simvastin in 2010. Eleven patients who used 80
milligrams of the statin drug per day developed Zocor rhabdomyolysis compared to none among
those Tuesday, October 11, 2011
Could Zocor Liver Damage Lead to Lawsuits?
Wednesday, October 5, 2011
Zocor Lawsuits More Muscle Injury than Other Side Effects
Zocor is a popular medication that is prescribed to patients
at risk of heart disease. It is a statin drug, which has proven effective in
managing high cholesterol levels in patients for whom cholesterol levels are a
problem or a contributing factor to heart disease. Zocor and other statin
medications have been a great deal of help to a significant number of at-risk
patients, but for others, side effects of the Zocor statin medication have been a detriment
to their health.
Zocor has been linked to many serious muscle conditions,
including rhabdomyolysis and myopathy. Zocor myopathy is a muscle condition that
involves the deterioration of muscle tissue, leading to muscle weakness or
injury, and in severe cases can manifest as Zocor rhabdomyolysis, in which
Friday, September 30, 2011
Consumer Watch Group Calls For Ban of Zocor
Zocor
(simvastatin) is a synthetic statin developed by Merck that is designed to
lower cholesterol. Zocor is part of a class of drugs called statins that are
used to treat high LDL (bad) cholesterol.
Simvastatin is also sold in generic versions, and is an active ingredient in
the combination drugs Vytorin and Simcor. Muscle injury has long been
recognized as one of the possible Zocor side effects, and the labels of these
medications all bear warnings regarding this risk. In 2010, the U.S. Food and
Drug Administration (FDA) updated the labels of high-dose simvastatin to warn
of an association with muscle injuries.
The FDA
now says that doctors should no longer prescribe 80 milligrams of Zocor unless
a patient has already been taking the dose for a year without any apparent
trouble. But not everyone agrees that the warning goes far enough. Public Citizen
has placed the Zocor 80 mg doses on its “Do Not Use” list, following an FDA
warning about the risk of serious and potentially life-threatening muscle injury from Zocor that
was issued earlier this week. The FDA announced June 8 that it is recommending
that no new patients be started on an 80 mg Zocor (simvastatin) regimen,
due to the risk of high dose Zocor side effects including
Tuesday, September 27, 2011
Zocor Dose Matters in Patients With Side Effects
Cholesterol-lowering drugs like Zocor have been beneficial
to many patients since they hit markets, lowering the risk of heart disease and
stroke associated with high cholesterol levels in their bloodstream and other
complications that can manifest if a patient’s cholesterol is too high.
However, there may be serious Zocor side effects that can make taking
the drug more risky than beneficial.
The Food and Drug Administration released a warning in early
June warning against use of the highest dose (80 mg) of Zocor, as this dose has
been the one most obviously associated with serious side effects including
muscle damage, myopathy, and rhabdomyolysis. Muscle weakness and muscle pain have also been
linked to Zocor use and can have a serious impact on a patient’s health and
wellbeing.
Patients who file a Zocor lawsuit, as many have been doing, may be
more successful at gaining some kind of settlement if they were taking the 80mg
dose of Zocor as opposed to lower doses such as the 20mg dose. This is not to
say that patients on lower doses who experienced Zocor side effects will not be
eligible to file a lawsuit, but their cases may be more difficult to argue and
prove, and Zocor lawyers will be more likely to be able to help plaintiffs who
were taking the recently-banned high doses of Zocor because of the recent FDA
warning against the prescription of this dose.
Subscribe to:
Posts (Atom)

